Media:
Synopsis: Chronic kidney disease (CKD) has increased burden of cardiovascular (CV) disease and increases the risk of dying from a cardiovascular (CV) event. Moreover, end stage kidney disease elevates the risk of CV mortality up to 50% of deaths. CKD changes vascular architecture not only by atherosclerosis (characterized by intima thickening) but also but arteriosclerosis (characterized by arterial stiffening and loss of arterial cushioning effect). Progression of atherosclerosis is related to CKD progression as well as to the baseline presence of atheroma plaque. Even A2 microalbuminuria (>30 mg/g of urinary creatinine) is associated with an increased risk of CV mortality and it is independent from the impact of GFR. The risk of major CV events can be reduced by LDL cholesterol lowering, effective treatment of diabetes and bone mineal disorder.
This agenda item is presented in the following session: S2 - Early atherosclerosis, hypertension and personalised prevention
Plenary session
03.12.2021 11:45 - 13:15